about
Intravesical liposome and antisense treatment for detrusor overactivity and interstitial cystitis/painful bladder syndromeSustained release of an anti-glaucoma drug: demonstration of efficacy of a liposomal formulation in the rabbit eyePartially polymerized liposomes: stable against leakage yet capable of instantaneous release for remote controlled drug delivery.Choroidal neovascularization reduced by targeted drug delivery with cationic liposome-encapsulated paclitaxel or targeted photodynamic therapy with verteporfin encapsulated in cationic liposomes.Recent applications of liposomes in ophthalmic drug delivery.Recent patents on ophthalmic nanoformulations and therapeutic implicationsNanoparticle-aptamer bioconjugates for cancer targeting.Ocular and systemic bio-distribution of rhodamine-conjugated liposomes loaded with VIP injected into the vitreous of Lewis rats.Light-activated nanoimpeller-controlled drug release in cancer cellsMolecularly imprinted therapeutic contact lenses.Feasibility of lipid nanoparticles for ocular delivery of anti-inflammatory drugs.Nanotechnology approaches for ocular drug delivery.Challenges and solutions in topical ocular drug-delivery systems.Topical delivery of ocular therapeutics: carrier systems and physical methods.Advances in ocular drug delivery: emphasis on the posterior segment.Nanocarriers of nanotechnology in retinal diseases.Pentablock copolymer dexamethasone nanoformulations elevate MYOC: in vitro liberation, activity and safety in human trabecular meshwork cells.Nanocarrier mediated retinal drug delivery: overcoming ocular barriers to treat posterior eye diseases.Pharmaceutical microscale and nanoscale approaches for efficient treatment of ocular diseases.Drug delivery to the eye: what benefits do nanocarriers offer?Intravesical liposome therapy for interstitial cystitis.Antifungal activity of a liposomal itraconazole formulation in experimental Aspergillus flavus keratitis with endophthalmitis.Optimization of dexamethasone mixed nanomicellar formulation.Supercritical fluid-mediated liposomes containing cyclosporin A for the treatment of dry eye syndrome in a rabbit model: comparative study with the conventional cyclosporin A emulsionRelevance of Lipid-Based Products in the Management of Dry Eye Disease.Ciprofloxacin liposomes as vesicular reservoirs for ocular delivery: formulation, optimization, and in vitro characterization.The extended ocular hypotensive effect of positive liposomal cholesterol bound timolol maleate in glaucomatous rabbits.Stimulus-responsive liposomes as smart nanoplatforms for drug delivery applications.High-Throughput Continuous Flow Production of Nanoscale Liposomes by Microfluidic Vertical Flow Focusing.Timolol maleate release from hyaluronic acid-containing model silicone hydrogel contact lens materials.Intracellular fluorescent thermometry and photothermal-triggered drug release developed from gold nanoclusters and doxorubicin dual-loaded liposomes.Preparation and ocular pharmacokinetics of hyaluronan acid-modified mucoadhesive liposomes.Ocular Drug, Gene and Cellular Delivery Systems and Advanced Therapy Medicinal Products.When nanotechnology meets the ocular surfaceEffective Delivery of Exogenous Compounds to the Optic Nerve by Intravitreal Injection of Liposome
P2860
Q21284684-FE805D52-4A3D-4F0D-A825-DF0501C9678EQ28477033-866C9253-3F6A-4F0D-BBF5-8B577E24EBB4Q33841749-E3CE40CC-5F8D-4038-B0D6-E8225136923EQ34555547-CD3EEF57-5CEC-43CB-BAA1-D189D7CA52FAQ34734683-2BEB37C9-E62F-48CF-9E10-B6723398611BQ35043004-40035344-094D-42B7-9DDF-2D13D486B228Q36460842-3740EDE3-4AFA-420F-B089-5D256443629EQ36498879-22F1F4DD-1261-433E-B248-87B352BE8A35Q37266438-AE465B79-70FC-45C2-A7F4-566672C1201FQ37735178-839822B9-0C33-4AEF-9C23-6D56C0652D1EQ37769529-9EEF8678-2436-4005-B0AF-31C2B6642414Q38098509-D057D65C-71FD-478F-9153-5D67205D6740Q38177335-BCB90AD7-B844-471F-8590-41AA4C73260FQ38196446-63ECDA99-F775-4B05-97DF-CD09E94F6F1AQ38224320-1239A6D9-A77B-4440-8F43-AD0D044F785DQ38282885-326127FC-9D6C-4D9B-B5E2-86AA70D25D17Q38653159-DC2E408A-42FD-456D-98E1-E5E98FCD93DCQ38829320-DA376698-F2C5-4A10-9A58-90F8F1ACBAB3Q38987118-CBE5B023-2804-4631-98D9-6474A73844BAQ39130097-0017FB70-948E-4126-A84C-351C654EC1E5Q39160922-0DBCE9FA-47EB-4036-8B90-88D064A4277EQ41645060-6CD0B7E5-CF38-4801-85AB-3A83B89F85A2Q41987702-9020C341-61BA-4736-B3AA-13FF8EA83923Q42792794-A9976F6C-3503-4B41-AAE6-5619640E3C82Q43119649-27DEFBF4-52AC-4AD6-923E-B8C47F841D27Q46220374-AA3DB416-2708-4EFC-99DB-18CE260A5302Q46260587-F6252A60-A1C8-4335-AB25-144C9D34E3DFQ50060960-74A86303-BBAE-4ED7-9E49-5E1A184E2AD3Q51481558-0F109D38-0CAD-40D9-8754-4FAC6E82EB4BQ53259773-812422AB-5826-4828-ADA6-CAC7AD210E84Q53645660-69C0E81C-FDD6-4AAF-AC8E-75DAC5E22587Q53655341-F228CEBF-857C-470B-AA06-FFABBD241F89Q55472392-CC89DA70-E5FF-4FFA-B090-DE343C6B6E08Q57381955-1DA7B6F1-6B30-45E9-9B31-9D5A2CF1611CQ57488293-64324C6D-D9D8-4DFE-90E4-942EED20A2D6
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
Applications of liposomes in ophthalmology.
@ast
Applications of liposomes in ophthalmology.
@en
type
label
Applications of liposomes in ophthalmology.
@ast
Applications of liposomes in ophthalmology.
@en
prefLabel
Applications of liposomes in ophthalmology.
@ast
Applications of liposomes in ophthalmology.
@en
P2093
P1476
Applications of liposomes in ophthalmology.
@en
P2093
Gholam A Peyman
Paul J Lee
Shehab Ebrahim
P304
P356
10.1016/J.SURVOPHTHAL.2004.12.006
P577
2005-03-01T00:00:00Z